Expression of PD1, COPD and lung cancer.
Conclusions: Our preliminary results show that patients with COPD have increased expression of PD1 in T lymphocytes that could block antitumor immunity.Supported in part by: SEPAR 2016 and IdISBa
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Verdu Rivera, F. J., Cunill Monjo, V., Luna Lopez, M. I., Andreu Matillas, V., Iglesias Coma, A., Pons De Ves, J., Alonso Fernandez, A., Garcia-Cosio Piqueras, F. D. B., Cerda Moncadas, M., Sauleda Roig, J. Tags: Lung Cancer Source Type: research
More News: Bronchoscopy | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Lung Cancer | Respiratory Medicine | Spirometry